Patent Assignment
Reel/Frame 017555/0284
Change of Name
Recorded: 2006-05-01
Pages: 4
Assignor
PROTEIN DESIGN LABS, INC.
Executed: 2006-01-09
Assignee
PDL BIOPHARMA, INC.
34801 CAMPUS DRIVE, FREMONT, CALIFORNIA, 94555
Covered Properties
(3)
Novel Methods of Diagnosing of Colorectal Cancer, Compositions, and Methods of Screening for Colorectal Cancer Modulators
Patent:
6,773,878 →
Application:
09/435,945 →
Novel Methods of Diagnosing Cancer, Compositions, and Methods of Screening for Cancer Modulators
Patent:
6,566,502 →
Application:
09/608,821 →
Novel Methods for Detection and Diagnosing of Breast Cancer
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 6, 2004
From: EOS BIOTECHNOLOGY, INC.
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 014967/0744 →
Merger
May 1, 2006
From: EOS BIOTECHNOLOGY, INC.
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 017555/0288 →
Assignment of Assignor's Interest
Dec 15, 2009
From: PDL BIOPHARMA, INC.
To: FACET BIOTECH CORPORATION
Reel/Frame 023649/0752 →
Change of Name
Dec 7, 2010
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 025445/0807 →
Change of Name
Nov 5, 2014
From: ABBOTT BIOTHERAPEUTICS CORP
To: ABBVIE BIOTHERAPEUTICS, INC.
Reel/Frame 034106/0766 →